Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma - Test2 - elhamkhani - TriplyDB

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

http://www.wikidata.org/entity/Q63817723

about

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

http://www.wikidata.org/entity/Q63817723

description

clinical trial

@en

klinisch onderzoek

@nl

name

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

@en

type

label

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

@en

prefLabel

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

@en

P1050

Q63817723-008ABF9D-0286-4EDF-B606-26AA135DD480

Q63817723-2606E26F-2283-44F6-9BE1-693AFC2582BC

Q63817723-488C5D42-39C9-4E66-A4BD-1398FB8D517A

Q63817723-5AA7243B-C319-4F0A-A4A7-7D14ED95887D

Q63817723-632A1F33-5E76-48EA-B09C-2EF2ED6D2F00

Q63817723-C0CA9946-63F6-4F29-8EFB-FDB9D620C10B

Q63817723-FAC8672B-B7D6-447B-ADCD-30BF54A2BCB2

P1132

Q63817723-468D53D3-686B-4C71-9B10-5EACF7E7416F

P1476

Q63817723-6815FB14-9B37-4D39-B5C2-131EDCF3049C

P2899

Q63817723-A784DC58-5838-4AF4-8891-19E55885D237

P3098

Q63817723-26FE9EE6-3E23-4C0C-B2A9-4C8E5F7016DF

P31

Q63817723-3675FEB4-CD24-4C52-9511-6B50CF65FDA8

P580

Q63817723-4CABF811-65D4-42AE-9454-B647D61DA027

P582

Q63817723-8AB3118D-3DFE-45F7-A0AB-A2277442AB13

P6099

Q63817723-C5CCAC17-EE8A-4425-82E9-07D8622AFA06

P1050

plasmablastic lymphoma

mycosis fungoides

Lymphomatoid granulomatosis

immunoblastic lymphadenopathy

Intraocular lymphoma

P1132

60

http://www.w3.org/2001/XMLSchema#decimal

P1476

Phase II Study of MK-2206 in Patients With Relapsed Lymphoma

@en

P2899

18

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT01258998

http://www.w3.org/2001/XMLSchema#string

P31

P580

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial